Advertisement VisCorp completes additional $5 million private placement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

VisCorp completes additional $5 million private placement

VisCorp has completed an additional private equity financing of $5 million with two accredited investors for a total raise of $15.22 million. The funds will be used principally to fund the expansion of Chengdu Tianyin's manufacturing facility located in Chengdu.

The company previously has acquired all of the issued and outstanding capital stock of Raygere Limited, a company organized under the laws of the British Virgin Islands and Raygere’s shareholders. Raygere conducts its business through Chengdu Tianyin Pharmaceutical, a corporation organized in the People’s Republic of China.